PTX 0.00% 4.0¢ prescient therapeutics limited

From latest Ann: "The company plans to initiate Phase 1b/2...

  1. 313 Posts.
    From latest Ann: "The company plans to initiate Phase 1b/2 clinical trial of PTX-100 in multiple myeloma in H1 2015.".
    But yes, you're correct, PTX-200 is currently in Phase 1b/2. But this is one drug, two trials.
    I'll also correct myself...its Co-X-gene technology.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.0¢ 4.0¢ $1.5K 37.50K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 29248 1
View Market Depth
Last trade - 13.07pm 20/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.